Pharmaceutical

AI drug discovery company Genesis Therapeutics wins $200m in Series B round

The company’s generative and predictive AI-powered drug discovery platform is already being used by Eli Lilly.

Aug 22, 2023 - 20:00
AI drug discovery company Genesis Therapeutics wins $200m in Series B round
The company’s generative and predictive AI-powered drug discovery platform is already being used by Eli Lilly.
Read the original article

Tags:

Previous Article

Leo Pharma to acquire US company Timber Pharmaceuticals

Next Article

Roche And Exelixis’ Drug Combo Grabs Late-Stage Prostate Cancer Victory

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Is there $21 billion left for Covid response, or $5 billion? The White House is using fuzzy math

STAT+: Is there $21 billion left for Covid response, or...

Mar 30, 2023

Opinion: How the twin crises of climate change and poor public housing are harming people’s health

Opinion: How the twin crises of climate change and poor...

Aug 29, 2023

Pfizer RSV vaccine wins CDC recommendation for seasonal use only

Pfizer RSV vaccine wins CDC recommendation for seasonal...

Sep 22, 2023